Next Article in Journal
Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
Next Article in Special Issue
Neuroprotective and Anti-Inflammatory Activities of Allyl Isothiocyanate through Attenuation of JNK/NF-κB/TNF-α Signaling
Previous Article in Journal
A Quantitative Acetylomic Analysis of Early Seed Development in Rice (Oryza sativa L.)
Previous Article in Special Issue
Moringa Leaves Prevent Hepatic Lipid Accumulation and Inflammation in Guinea Pigs by Reducing the Expression of Genes Involved in Lipid Metabolism
Open AccessReview

Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease

by Ying Nie 1,2,†, Qinlu Lin 1,† and Feijun Luo 1,*
Laboratory of Molecular Nutrition, College of Food science and Engineering, National Engineering Laboratory for Deep Processing of Rice and Byproducts, Central South University of Forestry and Technology, Changsha 410004, China
Department of Animal Science and Technology, College of Hunan Biological and Electromechanical Polytechnic, Changsha 410128, China
Author to whom correspondence should be addressed.
These authors contribute equally to this work.
Int. J. Mol. Sci. 2017, 18(7), 1372;
Received: 5 May 2017 / Revised: 12 June 2017 / Accepted: 18 June 2017 / Published: 27 June 2017
(This article belongs to the Special Issue Natural Anti-Inflammatory Agents)
The incidence of inflammatory bowel disease (IBD) has increased considerably over the past few decades. In the present review, we discuss several disadvantages existing in the treatment of IBD and current understandings of the structures, sources, and natures of various kinds of non-starch polysaccharides (NSPs). Available evidences for the use of different sources of NSPs in IBD treatment both in vitro and in vivo are analyzed, including glucan from oat bran, mushroom, seaweed, pectin, gum, prebiotics, etc. Their potential mechanisms, especially their related molecular mechanism of protective action in the treatment and prevention of IBD, are also summarized, covering the anti-inflammation, immune-stimulating, and gut microbiota-modulating activities, as well as short-chain fatty acids (SCFAs) production, anti-oxidative stress accompanied with inflammation, the promotion of gastric epithelial cell proliferation and tissue healing, and the reduction of the absorption of toxins of NSPs, thus ameliorating the symptoms and reducing the reoccurrence rate of IBD. In summary, NSPs exhibit the potential to be promising agents for an adjuvant therapy and for the prevention of IBD. Further investigating of the crosstalk between immune cells, epithelial cells, and gut microorganisms in addition to evaluating the effects of different kinds and different molecular weights of NSPs will lead to well-designed clinical intervention trials and eventually improve the treatment and prevention of IBD. View Full-Text
Keywords: non-starch polysaccharide (NSP); inflammatory bowel disease (IBD); intervention; mechanism; SCFAs; gut microbiota; immune system; pro-inflammatory cytokines non-starch polysaccharide (NSP); inflammatory bowel disease (IBD); intervention; mechanism; SCFAs; gut microbiota; immune system; pro-inflammatory cytokines
Show Figures

Graphical abstract

MDPI and ACS Style

Nie, Y.; Lin, Q.; Luo, F. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. Int. J. Mol. Sci. 2017, 18, 1372.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop